Position statement on the management of pregnancy in sickle cell disease
Sickle cell disease (SCD) is a hereditary haemoglobinopathy which causes multi-organ dysfunction. Pregnancies in SCD are high risk with significant maternal and fetal morbidity and mortality, including vaso-occlusive crises, thrombosis, anaemia, placental insufficiency, fetal growth restriction, preterm birth and medication effects. High level evidence on this topic is lacking. The Australian Sickle Cell Disease Working Group has reviewed international guidelines on this topic and provide an up-to-date and structured approach to the pre-conception, antenatal, birth and post-partum management of these women. Early and comprehensive multidisciplinary care involving experienced clinicians is recommended.
Authors
- Giselle Kidson‐Gerber (ORCID: https://orcid.org/0000-0001-5834-0890)
- Mimi Yue
- Zane Kaplan (ORCID: https://orcid.org/0000-0001-7689-9997)
- Debra Kennedy (ORCID: https://orcid.org/0000-0001-6874-4506)
- Kylie D. Mason (ORCID: https://orcid.org/0000-0002-6238-4092)
- Shelley Rowlands
Institutions
- Mater Health Services (AU)
- The Royal Melbourne Hospital (AU)
- Royal Women's Hospital (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Royal Hospital for Women (AU)
- Peter MacCallum Cancer Centre (AU)
- Prince of Wales Hospital (AU)
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Australian and New Zealand Journal of Obstetrics and Gynaecology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1111/ajo.13888
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- University of New South Wales